Contact Us

Yes. MPC2 rescue experiments require attention to heterodimer assembly and mitochondrial targeting: • Construct design: use a codon-modified MPC2 sequence with a small C-terminal tag (FLAG, HA). MPC2 has two transmembrane domains and forms an obligate heterodimer with MPC1 in the inner mitochondrial membrane — preserve all elements. • Mitochondrial localization validation: confirm inner mitochondrial membrane localization before functional assays. • MPC1 partnership: MPC2 requires MPC1 for stability — rescue interpretation considers MPC1 expression. Co-rescue of both subunits may be needed. • Functional readout: rescue should restore mitochondrial pyruvate import measured by ¹³C-pyruvate tracing into TCA cycle metabolites. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying MAOA (monoamine oxidase A)'s role as the principal serotonin/norepinephrine/dopamine catabolic enzyme or modeling Brunner syndrome. The Knockout line is the standard tool for asking whether MAOA is required for these activities — MAOA is a mitochondrial outer membrane flavin-dependent enzyme that oxidatively deaminates monoamine neurotransmitters (serotonin, norepinephrine, dopamine) and dietary tyramine, generating aldehydes and ammonia plus H₂O₂. Overexpression is useful for studying MAOA in heterologous expression contexts. For neurotransmitter research, the EDITGENE MAOA Knockout in HAP1 enables study of MAOA biology in vitro — physiological MAOA function in neuronal contexts requires brain-relevant models. MAOA loss-of-function mutations cause Brunner syndrome (X-linked, characterized by mild intellectual disability and impulsive aggression). Rescue with wild-type or catalytically-dead MAOA is the standard specificity control. The knockout is a critical specificity tool for MAOI antidepressants (phenelzine, tranylcypromine, selegiline, moclobemide) and MAOA-targeted research.

Yes. MAOA rescue experiments require attention to mitochondrial outer membrane targeting: • Construct design: use a codon-modified MAOA sequence with a small C-terminal tag (FLAG, HA). MAOA has N-terminal hydrophobic region (not cleaved) and C-terminal mitochondrial outer membrane anchor — preserve all elements including the C-terminal MOM anchor. • Mitochondrial localization validation: confirm mitochondrial outer membrane localization by TOM20 co-staining or differential subcellular fractionation. • Catalytically-dead rescue: FAD-binding residue mutations (C406A in the covalent FAD-binding cysteine) abolish enzymatic activity and serve as the standard specificity control. • Brunner syndrome mutation rescue: patient-derived MAOA mutations enable disease genotype-function studies. • Functional readout: rescue should restore monoamine oxidative deamination activity measured by substrate consumption (LC-MS) or H₂O₂ generation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying MAP3K10 (MLK2)'s role as an MLK family MAP3K or its functions distinct from MLK1 (MAP3K9) and MLK3 (MAP3K11). The Knockout line is the standard tool for asking whether MLK2 is required for predicted activities — MLK2 activates JNK and p38 pathways with overlapping substrate scope to MLK1 and MLK3. Overexpression is useful for studying MLK2 in heterologous expression contexts. Important consideration: MLK1, MLK2, MLK3 share substantial functional overlap — single MAP3K10 knockout may show modest phenotypes if other MLKs compensate. Rescue with wild-type or kinase-dead MAP3K10 is the standard specificity control. This product complements the parallel MAP3K9 (MLK1) Knockout in HAP1 (also available) for MLK family paralog-specific dissection. The knockout is valuable for testing pan-MLK inhibitors (CEP-1347, URMC-099) in neuroprotection research.

Yes. MLK2 rescue experiments require attention to MLK family architecture: • Construct design: use a codon-modified MAP3K10 sequence with a small C-terminal tag (FLAG, HA). MLK2 has the canonical MLK family architecture (SH3, kinase, LZ, CRIB, regulatory) — preserve all elements. • Kinase-dead rescue: ATP-binding lysine mutation abolishes catalytic activity. • CRIB-mutant rescue: CRIB motif mutations disrupt Rac1/Cdc42 binding. • Functional readout: rescue should restore JNK pathway activation following stress stimuli. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

Important clarification: MAP2 (microtubule-associated protein 2) is a structural/scaffolding protein, NOT a kinase, despite the 'MAP' prefix that is also used in 'MAP kinase' (MAPK) nomenclature. MAP2 belongs to the microtubule-associated protein family (with MAP1A, MAP1B, MAP4, tau/MAPT) that binds and stabilizes microtubules. The choice between knockout and overexpression depends on whether you are studying MAP2's role in microtubule stabilization, dendrite morphology, or as a neuronal marker. The Knockout line is the standard tool for asking whether MAP2 is required for dendrite-specific microtubule stabilization — MAP2 is highly enriched in neuronal dendrites and is one of the most widely used dendrite markers in neuroscience research. Important consideration: MAP2 is principally expressed in neurons (and is a defining marker of neuronal differentiation) — HAP1 is not the physiological context for canonical MAP2 functions. The EDITGENE MAP2 Knockout in HAP1 is most useful for biochemistry, heterologous expression studies, and as a clean genetic background for MAP2 structure-function research. Rescue with wild-type MAP2 enables structure-function studies. For physiologically relevant MAP2 research, neuronal models (primary neurons, iPSC-derived neurons) are more appropriate.

Yes. MAP2 rescue experiments require attention to splice isoform diversity: • Construct design: use a codon-modified MAP2 sequence with a small C-terminal tag (FLAG, HA). MAP2 has multiple isoforms (MAP2a/b — large dendritic; MAP2c — embryonic and adult brain; MAP2d) — choose the isoform appropriate to the experimental question. • Microtubule-binding-deficient rescue: microtubule-binding domain mutations (basic residue mutations in MT-binding region) abolish microtubule association and serve as the standard specificity control. • Phosphorylation-resistant rescue: phospho-site mutations (multiple PKA/MARK substrate sites) generate phosphorylation-resistant MAP2 for studying phosphorylation-dependent regulation. • Functional readout: rescue should restore microtubule stabilization in vitro and dendrite-like processes in heterologous contexts. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying MBD2 (methyl-CpG binding domain protein 2)'s role as a methylated DNA reader within the NuRD chromatin remodeling complex or its emerging functions in tumor suppression. The Knockout line is the standard tool for asking whether MBD2 is required for these processes — MBD2 binds methylated CpG islands through its conserved MBD domain and recruits the NuRD complex (containing HDAC1/2, CHD3/4, MTA1/2/3, RBBP4/7) to repress methylated gene promoters. Overexpression is useful for studying MBD2 in heterologous expression contexts. For breast cancer epigenetics research, the EDITGENE MBD2 Knockout in T-47D-CAS9 is highly relevant — T-47D is a luminal A breast cancer cell line (ER+, PR+, HER2-), and MBD2-NuRD-mediated repression of tumor suppressor genes contributes to luminal breast cancer biology. Rescue with wild-type or MBD-domain-mutant (methylated DNA-binding deficient) MBD2 enables structure-function studies. The knockout is valuable for studying MBD2-targeted approaches in cancer and emerging anti-NuRD therapeutic strategies. The constitutive Cas9 expression in T-47D-CAS9 enables further combinatorial gene editing studies.

Yes. MBD2 rescue experiments require attention to NuRD complex integration: • Construct design: use a codon-modified MBD2 sequence with a small C-terminal tag (FLAG, HA). MBD2 has N-terminal MBD (methyl-CpG binding) domain and C-terminal coiled-coil for NuRD complex recruitment — preserve all elements. • MBD-domain-mutant rescue: methylated DNA-binding residue mutations (e.g., R26A, Y34A in the MBD pocket) abolish methylated DNA binding and serve as the standard specificity control. • NuRD-binding-deficient rescue: coiled-coil mutations disrupt NuRD recruitment. • Functional readout: rescue should restore methylated gene silencing and NuRD complex recruitment to target promoters. T-47D-CAS9-specific considerations: • T-47D-CAS9 is a luminal A breast cancer cell line (ER+, PR+, HER2-) constitutively expressing Cas9 for additional editing — the Cas9 expression must be considered when designing further knockout or rescue experiments. • Hormone receptor positivity makes T-47D-CAS9 a relevant model for hormone-dependent breast cancer biology. • Lentiviral transduction is supported; the Cas9 expression cassette location should be characterized before designing complex multi-locus modifications.

The choice depends on whether you are studying MC1R (melanocortin-1 receptor)'s role as the principal regulator of eumelanin versus pheomelanin synthesis or modeling MC1R variant-associated melanoma risk and UV protection. The Knockout line is the standard tool for asking whether MC1R is required for these processes — MC1R is a Gs-coupled GPCR expressed on melanocytes that, upon α-MSH binding, drives cAMP-PKA-MITF signaling to switch from pheomelanin (light-protective-poor) to eumelanin (dark-protective) synthesis. Overexpression is useful for studying MC1R in heterologous expression contexts. For melanoma research, the EDITGENE MC1R Knockout in A-375 is highly informative — A-375 is a BRAF V600E-mutant melanoma cell line, and MC1R loss-of-function variants (red hair color/RHC variants R151C, R160W, D294H) confer 2-4 fold increased melanoma risk and reduced UV photoprotection. Rescue with wild-type or RHC-variant (R151C, R160W, D294H, V60L) MC1R enables comprehensive disease genotype-function studies. The knockout is a critical specificity control for MC1R agonists (afamelanotide/Scenesse, approved for erythropoietic protoporphyria photoprotection) and emerging MC1R-targeted skin protection compounds.

Yes. MC1R rescue experiments are well-established for melanoma and pigmentation research: • Construct design: use a codon-modified MC1R sequence with a small intracellular C-terminal tag (FLAG, HA). MC1R is a seven-transmembrane GPCR — N-terminal tags after the signal peptide are tolerated. • RHC variant rescue: red hair color-associated variants (R151C, R160W, D294H, V60L) introduced for melanoma risk genotype-function studies. • Signaling-deficient rescue: DRY motif mutations disrupt Gs-coupling without affecting α-MSH binding. • Functional readout: rescue should restore α-MSH-induced cAMP elevation (Gs signaling) and MITF target gene expression. A-375-specific considerations: • A-375 is a human melanoma cell line (BRAF V600E-mutant) — a standard model for melanoma biology and MAPK pathway-driven cancer research. • A-375 transduces efficiently with lentivirus and supports stable rescue line generation. • The BRAF V600E background should be considered when interpreting MAPK pathway-related phenotypes.

The choice depends on whether you are studying MMP16 (MT3-MMP)'s role as a transmembrane membrane-type matrix metalloproteinase or its functions in tissue remodeling and pro-MMP-2 activation. The Knockout line is the standard tool for asking whether MMP16 is required for these processes — MMP16 is a type I transmembrane MT-MMP that activates pro-MMP-2 at the cell surface and degrades various ECM substrates (collagen III, fibronectin, vitronectin). Overexpression is useful for studying MMP16 in heterologous expression contexts. For matrix metalloproteinase research, the EDITGENE MMP16 Knockout in HAP1 enables study of MT3-MMP biology. Other MT-MMP (MMP14, MMP15) expression analysis is essential given functional overlap in pro-MMP-2 activation. Rescue with wild-type or catalytically-dead MMP16 is the standard specificity control. This product complements parallel MMP15 and MMP25 Knockouts in HAP1 for MT-MMP family functional dissection.

Yes. MMP16 rescue experiments require attention to transmembrane topology: • Construct design: use a codon-modified MMP16 sequence with a small intracellular C-terminal tag (FLAG, HA). MMP16 has N-terminal signal/prodomain, extracellular catalytic domain, hinge, hemopexin domain, single transmembrane span, and short cytoplasmic tail — preserve all elements. • Catalytically-dead rescue: HEXXH motif glutamate mutation (E to A) abolishes metalloprotease activity. • Prodomain processing: active MMP16 is generated by furin processing of the prodomain — confirm mature MMP16 form after rescue. • Functional readout: rescue should restore pro-MMP-2 activation (zymography) and ECM substrate degradation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying combined MKNK1/MKNK2 (MNK1/MNK2) function for phospho-eIF4E generation or distinguishing MNK-mediated translation regulation from MNK-independent processes. The Double Knockout line is uniquely valuable for asking whether MNK-mediated eIF4E phosphorylation is required for these processes — MNK1 and MNK2 are functionally redundant kinases that phosphorylate eIF4E at S209 downstream of MAPK pathways (ERK activates MNK1; p38 activates both). Single MNK1 or MNK2 KO shows minimal effect on phospho-eIF4E because of paralog compensation; double KO eliminates phospho-eIF4E entirely. Single-MNK rescue (MNK1 alone or MNK2 alone) in the double knockout enables paralog-specific functional dissection. For translation regulation and cancer research, the EDITGENE MKNK1 & MKNK2 Double Knockout in HeLa is the gold-standard genetic tool — combined loss is essential to abolish phospho-eIF4E, the well-characterized cancer-relevant translation control mark. Single-MNK rescue is the gold-standard experimental design for distinguishing paralog-specific functions. The double knockout is a critical specificity control for tomivosertib (eFT508, a clinical MNK1/2 inhibitor in cancer trials), BAY 1143269, and other MNK-targeting compounds. Phospho-eIF4E supports translation of oncoprotein mRNAs (MYC, MCL1, BCL2) and is a validated cancer target.

Yes, and rescue experiments are uniquely powerful in this double knockout: • Single-MNK rescue: re-introduction of MNK1 alone or MNK2 alone in the double knockout enables paralog-specific functional dissection — the gold-standard experimental design for redundant MAPK-activated kinases. • Construct design: use codon-modified MKNK1 or MKNK2 sequences with small C-terminal tags (FLAG, HA). MNK1 and MNK2 have N-terminal eIF4G-binding region, central kinase domain, and C-terminal MAPK-binding region — preserve all elements. • Kinase-dead rescue: K78R (MNK1) or K113R (MNK2) ATP-binding lysine mutations abolish catalytic activity for paralog-specific catalytic dissection. • Constitutively active rescue: T197E/T202E (MNK1) phospho-mimetic mutations in the activation loop generate constitutively active MNKs for gain-of-function studies. • Functional readout: rescue should restore phospho-eIF4E (S209) levels and downstream cap-dependent translation of MNK-target mRNAs. HeLa transduces efficiently with lentivirus and supports systematic paralog-specific rescue experiments.